Page last updated: 2024-08-23

lovastatin and Arteriosclerosis, Coronary

lovastatin has been researched along with Arteriosclerosis, Coronary in 75 studies

Research

Studies (75)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (1.33)	18.7374
1990's	46 (61.33)	18.2507
2000's	26 (34.67)	29.6817
2010's	2 (2.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Girotra, S; Mittleman, MA; Mukamal, KJ; Wee, CC; Weinstein, AR	1
Chonchol, M; Cook, T; Kendrick, J; Lindenfeld, J; Shlipak, MG; Targher, G	1
Davydova, N; Gotfrid, I; Kerimkulova, A; Lunegova, O; Mirrakhimov, A; Mirrakhimov, E; Moldokeeva, C; Noruzbaeva, A	1
Mehta, JL; Singh, BK	1
Mishra, TK; Routray, S	1
Aicher, A; Badorff, C; Dimmeler, S; Fichtlscherer, S; Koyanagi, M; Rupp, S; Urbich, C; Zeiher, AM	1
Fang, CH; Li, JJ	1
Hodis, HN; Mack, WJ; Mahrer, PR; Selzer, RH; Vigen, C	1
Gotto, AM	4
Clearfield, M; Downs, JR; Gotto, AM; Langendorfer, A; Lee, M; McConathy, W	1
Rosenson, RS	1
Karlamangla, AS; Moore, AA; Mukamal, KJ; Smith, CC	1
Abrahamson, D; Detrano, RC; Franklin, SS; Henein, N; Kashyap, ML; Kukes, G; Rosenzweig, B; Teng, W; Willner, R; Wong, ND	1
Boccuzzi, SJ; Cook, T; Gladstone, P; Higginson, L; Lespérance, J; Waters, D	1
Stehbens, WE	1
Alexander, RW; Boccuzzi, SJ; Cedarholm, JC; Klein, JL; Kosinski, AS; Stillabower, ME; Talley, JD; Treasure, CB; Weintraub, WS; Zhang, J	1
Anderson, TJ; Frei, B; Ganz, P; Meredith, IT; Selwyn, AP; Yeung, AC	1
Kulbertus, H; Legrand, V; Martinez, C	1
Davies, G; Kitano, Y; Maher, VM; Matthews, S; Mir, A; Neuwirth, C; Prescott, RJ; Rees, A; Shortt, MB; Thompson, GR	1
Alonso-Pulpón, L; Anguita, M; Arizón, JM; Cavero, MA; Concha, M; Crespo, M; Pérez-Jiménez, F; Segovia, J; Vallés, F	1
Alaupovic, P; Blankenhorn, DH; Cashin-Hemphill, L; Corder, CN; Hodis, HN; Knight-Gibson, C; Kramsch, DM; LaBree, L; Mack, WJ	1
Alaupovic, P; Azen, SP; Blankenhorn, DH; Hemphill, LC; Hodis, HN; Kramsch, DM; LaBree, L; Mack, WJ; Pogoda, JM	1
Boccuzzi, SJ; Gladstone, P; Higginson, L; Kimball, B; Le May, M; Lespérance, J; Waters, D	1
Dudrick, SJ; Edens, RP; Goldberg, DI; Gould, KL; Hess, MJ; Latifi, R; Martucci, JP	1
Dumont, JM	1
Gladstone, P; Higginson, L; Kimball, B; LeMay, M; Lespérance, J; Waters, D	1
Aengevaeren, WR; Bruschke, AV; Kroon, AA; Reiber, JH; Stalenhoef, AF; Uijen, GJ; van der Werf, T	1
Drown, DJ	1
Boccuzzi, SJ; Cook, T; Gladstone, P; Higginson, L; Hudgin, R; Krip, G; Lespérance, J; Waters, D	1
Bateman, TM; Conn, RD; Lavie, CJ; O'Keefe, JH	1
Rackley, CE	1
Pederson, JP; Weintraub, WS	1
Aengevaeren, WR; Kroon, AA; Stalenhoef, AF; Uijen, GJ; van der Werf, T	1
Hodis, HN; Krauss, RM; Mack, WJ	1
Kroon, AA; Stalenhoef, AF; van Asten, WN	1
Avila, PC	1
Buller, C; Burton, JR; Montague, TJ; Plante, S; Teo, KK; Yokoyama, S	1
Beere, PA; Clearfield, M; Downs, JR; Gotto, AM; Langendorfer, A; Rochen, J; Shapiro, DR; Stein, EA; Weis, S; Whitney, E	1
Albers, J; Brown, BG; Chait, A; Cheung, M; DeAngelis, D; Dowdy, A; Fisher, LD; Frohlich, J; Heise, N; Zhao, XQ	1
Mabuchi, H	1
Brown, BG; Brunzell, JD; Hokanson, JE; Zambon, A	1
Stankler, L	1
Assmann, G; Breithardt, G; Eckert, S; Fleck, E; Gleichmann, U; Hanrath, P; Kerber, S; Kleemann, A; Lepper, W; Neiss, A; Schernikau, U; von Eckardstein, A	1
Beere, PA; Clearfield, M; de Cani, JS; Downs, JR; Gotto, AM; Jou, JY; Langendörfer, A; Shapiro, DR; Stein, EA; Watson, DJ; Weis, S; Whitney, E	2
Beere, PA; Clearfield, M; Downs, JR; Gotto, AM; Langendörfer, A; Shapiro, DR; Stamler, J; Stein, EA; Watson, DJ; Weis, S; Whitney, EJ	1
Verdery, R	1
Alexander, CM; Boccuzzi, SJ; Clearfield, M; Cook, JR; Gotto, AM; Meyer, GS; Roehm, JB; Weis, S; Whitney, E	1
Gotto , AM	1
Whitney, E	1
Ganz, P; Kinlay, S; Orford, JL; Selwyn, AP	1
Beere, PA; Clearfield, M; Downs, JR; Gotto, AM; Kruyer, W; Langendorfer, A; Shapiro, DR; Tyroler, HA; Weis, S; Whitney, EJ; Zagrebelsky, V	1
Schwartz, JB	1
Campeau, L; Forman, SA; Forrester, JS; Geller, NL; Gobel, FL; Herd, JA; Hickey, A; Hoogwerf, BJ; Hunninghake, DB; Knatterud, GL; Rosenberg, Y; Terrin, ML; White, CW	1
Blake, GJ; Ridker, PM	1
Beere, PA; Clearfield, M; Downs, JR; Gotto, AM; Kruyer, W; Langendorfer, A; Shapiro, DR; Stein, EA; Weis, S; Whitney, EJ	1
Böhm, M; Hamm, CW; Heeschen, C; Laufs, U; Snapinn, S; White, HD	1
Clearfield, M; Cook, TJ; Downs, JR; Gotto, AM; Pradhan, AD; Ridker, PM; Shih, J; Weis, SE	1
Bengel, F; Jaeger, BR; Schwaiger, M; Seidel, D; Tsobanelis, T	1
Azen, SP; Cashin-Hemphill, L; DeBoer, L; DeBoer, LW; DeMets, D; Hirsch, LJ; Hwang, I; Kramsch, DM; Mack, WJ; Vailas, L	1
Oliver, MF	1
Walker, JF	1
Brown, BG	1
Kukharchuk, V; Martinov, A; Pomerantsev, E; Shabalkin, B; Titov, V; Yurenev, A; Zhukova, I	1
Szamosi, A	1
Oogushi, K	1
Diehl, JC; Havel, RJ; Kane, JP; Malloy, MJ; Phillips, NR; Ports, TA	1
Bochkova, EI; Iurenev, AP; Kotkina, AA; Lediashova, GA; Martynov, AA; Pomerantsev, EV; Shabalkin, BV; Shimbaeva, NA; Titov, VN; Zhukova, IM	1
Barlow, CW; Friedman, BM; Myburgh, DP; Smith, DH; Soicher, ER; Steenkamp, WF	1
Iurenev, AP; Kiseleva, OA; Lediashova, GA; Pomerantsev, EV; Zhukova, IM	1

Reviews

9 review(s) available for lovastatin and Arteriosclerosis, Coronary

Article	Year
Management of dyslipidemia in the primary prevention of coronary heart disease. Current opinion in cardiology, 2002, Volume: 17, Issue:5 Topics: Animals; Cholesterol, HDL; Clinical Trials as Topic; Coronary Artery Disease; Coronary Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lovastatin; Practice Guidelines as Topic; Pravastatin; Risk Factors	2002
Review of primary and secondary prevention trials with lovastatin, pravastatin, and simvastatin. The American journal of cardiology, 2005, Sep-05, Volume: 96, Issue:5A Topics: Coronary Artery Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Pravastatin; Randomized Controlled Trials as Topic; Simvastatin	2005
The new paradigm for coronary artery disease: altering risk factors, atherosclerotic plaques, and clinical prognosis. Mayo Clinic proceedings, 1996, Volume: 71, Issue:10 Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Antioxidants; Coronary Angiography; Coronary Artery Disease; Endothelium, Vascular; Exercise Test; Humans; Hypercholesterolemia; Inflammation; Lovastatin; Platelet Aggregation Inhibitors; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Simvastatin	1996
Monotherapy with HMG-CoA reductase inhibitors and secondary prevention in coronary artery disease. Clinical cardiology, 1996, Volume: 19, Issue:9 Topics: Carotid Artery Diseases; Clinical Trials as Topic; Coronary Artery Disease; Coronary Disease; Enzyme Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Pravastatin; Simvastatin	1996
Lipid altering or antioxidant vitamins for patients with coronary disease and very low HDL cholesterol? The HDL-Atherosclerosis Treatment Study Design. The Canadian journal of cardiology, 1998, Volume: 14 Suppl A Topics: Adult; Aged; Antioxidants; Cholesterol, HDL; Coronary Angiography; Coronary Artery Disease; Coronary Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Myocardial Revascularization; Niacin; Simvastatin; Treatment Outcome; Vitamins	1998
[Hyperlipidemia and arteriosclerosis]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1998, May-10, Volume: 87, Issue:5 Topics: Anticholesteremic Agents; Coronary Artery Disease; Coronary Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lovastatin; Pravastatin; Simvastatin	1998
Insights on treating an over-the-counter-type subgroup: data from the Air Force/Texas Coronary Atherosclerosis Prevention Study Population. The American journal of cardiology, 2000, Jun-22, Volume: 85, Issue:12A Topics: Aged; Anticholesteremic Agents; Cholesterol; Coronary Artery Disease; Female; Humans; Hyperlipidemias; Lovastatin; Male; Middle Aged; Military Personnel; Nutrition Surveys; Randomized Controlled Trials as Topic; Risk Factors; Texas	2000
Treating ambulatory ischemia in coronary disease by manipulating the cell biology of atherosclerosis. Current atherosclerosis reports, 2000, Volume: 2, Issue:4 Topics: Anticholesteremic Agents; Cholesterol, LDL; Coronary Artery Disease; Electrocardiography, Ambulatory; Endothelium, Vascular; Humans; Lovastatin; Male; Myocardial Ischemia; Risk Factors	2000
Lipid-lowering medications: what the new guidelines and data mean to women. The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia, 2001, Volume: 4, Issue:2 Topics: Age Factors; Atorvastatin; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lovastatin; Male; Practice Guidelines as Topic; Pyrroles; Triglycerides	2001

Trials

50 trial(s) available for lovastatin and Arteriosclerosis, Coronary

Article	Year
The relationship between obesity and atherosclerotic progression and prognosis among patients with coronary artery bypass grafts the effect of aggressive statin therapy. Journal of the American College of Cardiology, 2008, Aug-19, Volume: 52, Issue:8 Topics: Anticoagulants; Body Mass Index; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Disease Progression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Obesity; Postoperative Period; Prognosis; Prospective Studies; Warfarin	2008
Effect of lovastatin on primary prevention of cardiovascular events in mild CKD and kidney function loss: a post hoc analysis of the Air Force/Texas Coronary Atherosclerosis Prevention Study. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2010, Volume: 55, Issue:1 Topics: Aged; Coronary Artery Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Kidney Failure, Chronic; Kidney Function Tests; Lovastatin; Male; Middle Aged; Military Personnel; Primary Prevention; Texas; Time Factors; Treatment Outcome	2010
Influence of one-year treatment with lovastatin on myocardial remodeling and ischemia in patients with coronary artery disease. Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology, 2011, Volume: 11, Issue:1 Topics: Adult; Aged; Coronary Artery Disease; Diet, Fat-Restricted; Dyslipidemias; Echocardiography; Electrocardiography, Ambulatory; Exercise; Exercise Test; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Lovastatin; Male; Middle Aged; Myocardial Ischemia; Prospective Studies; Stroke Volume; Ventricular Function, Left; Ventricular Remodeling	2011
Statin therapy in patients with coronary artery disease improves the impaired endothelial progenitor cell differentiation into cardiomyogenic cells. Basic research in cardiology, 2004, Volume: 99, Issue:1 Topics: Adult; Animals; Anticholesteremic Agents; Atorvastatin; Cell Differentiation; Cells, Cultured; Coronary Artery Disease; Endothelial Cells; Female; Heptanoic Acids; Humans; Lovastatin; Male; Myocytes, Cardiac; Pyrroles; Rats; Simvastatin	2004
Relation of progression of coronary artery atherosclerosis to risk of cardiovascular events (from the Monitored Atherosclerosis Regression Study). The American journal of cardiology, 2005, Jun-01, Volume: 95, Issue:11 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Disease; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Proportional Hazards Models	2005
Implications from the Air Force/Texas Coronary Atherosclerosis Prevention Study for the Adult Treatment Panel III guidelines. The American journal of cardiology, 2005, Dec-15, Volume: 96, Issue:12 Topics: Aged; Anticholesteremic Agents; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Double-Blind Method; Female; Follow-Up Studies; Humans; Lovastatin; Male; Metabolic Syndrome; Middle Aged; Military Personnel; Practice Guidelines as Topic; Retrospective Studies; Risk Factors; Treatment Outcome	2005
Moderate alcohol consumption and safety of lovastatin and warfarin among men: the post-coronary artery bypass graft trial. The American journal of medicine, 2006, Volume: 119, Issue:5 Topics: Adult; Aged; Alanine Transaminase; Alcohol Drinking; Anticholesteremic Agents; Anticoagulants; Coronary Artery Bypass; Coronary Artery Disease; Double-Blind Method; Humans; International Normalized Ratio; Lovastatin; Male; Middle Aged; Placebos; Warfarin	2006
Noninvasive tracking of coronary atherosclerosis by electron beam computed tomography: rationale and design of the Felodipine Atherosclerosis Prevention Study (FAPS). The American journal of cardiology, 1995, Dec-15, Volume: 76, Issue:17 Topics: Aged; Anticholesteremic Agents; Calcium; Calcium Channel Blockers; Coronary Artery Disease; Disease Progression; Drug Therapy, Combination; Felodipine; Female; Humans; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Research Design; Simvastatin; Tomography, X-Ray Computed	1995
Effects of cholesterol lowering on the progression of coronary atherosclerosis in women. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) substudy. Circulation, 1995, Nov-01, Volume: 92, Issue:9 Topics: Adult; Aged; Anticholesteremic Agents; Cholesterol; Coronary Angiography; Coronary Artery Disease; Female; Follow-Up Studies; Humans; Lovastatin; Male; Middle Aged; Multivariate Analysis; Sex Factors	1995
Validity of the 4S simvastatin trial. Lancet (London, England), 1995, Jan-28, Volume: 345, Issue:8944 Topics: Adult; Anticholesteremic Agents; Controlled Clinical Trials as Topic; Coronary Artery Disease; Humans; Hydroxymethylglutaryl-CoA Synthase; Lovastatin; Middle Aged; Research Design; Simvastatin	1995
Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. The New England journal of medicine, 1995, Feb-23, Volume: 332, Issue:8 Topics: Acetylcholine; Coronary Artery Disease; Dose-Response Relationship, Drug; Double-Blind Method; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Lovastatin; Male; Middle Aged; Nitroglycerin; Prospective Studies; Recurrence; Vasodilation	1995
The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. The New England journal of medicine, 1995, Feb-23, Volume: 332, Issue:8 Topics: Acetylcholine; Anticholesteremic Agents; Antioxidants; Cholestyramine Resin; Coronary Artery Disease; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Probucol; Regression Analysis; Vasoconstriction; Vasodilation	1995
Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS) Lancet (London, England), 1994, Sep-03, Volume: 344, Issue:8923 Topics: Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Double-Blind Method; Female; Follow-Up Studies; Humans; Lipids; Lovastatin; Male; Middle Aged; Myocardial Infarction; Simvastatin; Treatment Outcome	1994
[Moderate hypercholesterolemia and coronary disease: the MAAS study and the 4S study]. Revue medicale de Liege, 1995, Volume: 50, Issue:1 Topics: Anticholesteremic Agents; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Humans; Hydroxymethylglutaryl-CoA Synthase; Hypercholesterolemia; Lovastatin; Middle Aged; Primary Prevention; Risk Factors; Simvastatin	1995
Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis. Lancet (London, England), 1995, Apr-01, Volume: 345, Issue:8953 Topics: Adult; Blood Component Removal; Cholestyramine Resin; Colestipol; Coronary Angiography; Coronary Artery Disease; Data Interpretation, Statistical; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipids; Lipoprotein(a); Lipoproteins, LDL; Lovastatin; Middle Aged; Odds Ratio; Simvastatin	1995
Comparison of the effectiveness of lovastatin therapy for hypercholesterolemia after heart transplantation between patients with and without pretransplant atherosclerotic coronary artery disease. The American journal of cardiology, 1994, Oct-15, Volume: 74, Issue:8 Topics: Cholesterol; Coronary Artery Disease; Female; Heart Transplantation; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Treatment Outcome; Triglycerides	1994
Effects of lovastatin on ApoA- and ApoB-containing lipoproteins. Families in a subpopulation of patients participating in the Monitored Atherosclerosis Regression Study (MARS). Arteriosclerosis and thrombosis : a journal of vascular biology, 1994, Volume: 14, Issue:12 Topics: Adult; Aged; Apolipoproteins A; Apolipoproteins B; Cholesterol; Coronary Artery Disease; Disease Progression; Drug Monitoring; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Triglycerides	1994
Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin. Circulation, 1994, Volume: 90, Issue:1 Topics: Adult; Aged; Cholesterol; Coronary Angiography; Coronary Artery Disease; Double-Blind Method; Female; Humans; Lipoproteins; Lovastatin; Male; Middle Aged; Regression Analysis; Risk Factors; Triglycerides	1994
Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial. Circulation, 1994, Volume: 89, Issue:3 Topics: Canada; Cholesterol; Coronary Angiography; Coronary Artery Disease; Double-Blind Method; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Lovastatin; Male; Middle Aged; Multivariate Analysis; Time Factors	1994
Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium. Circulation, 1994, Volume: 89, Issue:4 Topics: Adult; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Coronary Artery Disease; Dietary Fats; Dipyridamole; Female; Food, Formulated; Heart; Humans; Image Processing, Computer-Assisted; Lovastatin; Male; Parenteral Nutrition, Total; Time Factors; Tomography, Emission-Computed	1994
Effect of cholesterol reduction by simvastatin on progression of coronary atherosclerosis: Design, baseline characteristics, and progress of the Multicenter Anti-Atheroma Study (MAAS). Controlled clinical trials, 1993, Volume: 14, Issue:3 Topics: Adult; Aged; Cholesterol, Dietary; Coronary Angiography; Coronary Artery Disease; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl CoA Reductases; Hypolipidemic Agents; Lipid Metabolism; Lipids; Lovastatin; Male; Middle Aged; Research Design; Treatment Outcome	1993
Design features of a controlled clinical trial to assess the effect of an HMG CoA reductase inhibitor on the progression of coronary artery disease. Canadian Coronary Atherosclerosis Intervention Trial Investigators Montreal, Ottawa, and Toronto, Canada. Controlled clinical trials, 1993, Volume: 14, Issue:1 Topics: Adult; Aged; Cholesterol; Clinical Trials as Topic; Coronary Angiography; Coronary Artery Disease; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Middle Aged; Myocardial Infarction; Survival Rate	1993
LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis. Circulation, 1996, May-15, Volume: 93, Issue:10 Topics: Adult; Aged; Anticholesteremic Agents; Blood Component Removal; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Enzyme Inhibitors; Exercise Test; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Middle Aged; Prospective Studies; Simvastatin	1996
Effects of cigarette smoking on the angiographic evolution of coronary atherosclerosis. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy. CCAIT Study Group. Circulation, 1996, Aug-15, Volume: 94, Issue:4 Topics: Adult; Angina, Unstable; Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Lovastatin; Male; Middle Aged; Myocardial Infarction; Placebos; Smoking; Triglycerides	1996
Low density lipoprotein apheresis improves regional myocardial perfusion in patients with hypercholesterolemia and extensive coronary artery disease. LDL-Apheresis Atherosclerosis Regression Study (LAARS). Journal of the American College of Cardiology, 1996, Volume: 28, Issue:7 Topics: Adult; Aged; Angiography, Digital Subtraction; Anticholesteremic Agents; Blood Component Removal; Combined Modality Therapy; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Female; Humans; Hypercholesterolemia; Lipoproteins, LDL; Lovastatin; Male; Middle Aged; Simvastatin	1996
Lipoprotein subclasses in the Monitored Atherosclerosis Regression Study (MARS). Treatment effects and relation to coronary angiographic progression. Arteriosclerosis, thrombosis, and vascular biology, 1996, Volume: 16, Issue:5 Topics: Adult; Aged; Animals; Coronary Angiography; Coronary Artery Disease; Disease Progression; Female; Humans; Lipoproteins; Lovastatin; Male; Middle Aged; Multivariate Analysis; Placebos; Regression Analysis; Remission Induction; Treatment Outcome	1996
Effect of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolemic patients with coronary artery disease. Annals of internal medicine, 1996, Dec-15, Volume: 125, Issue:12 Topics: Adult; Aged; Anticholesteremic Agents; Blood Component Removal; Cholesterol, LDL; Combined Modality Therapy; Coronary Artery Disease; Disease Progression; Enzyme Inhibitors; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Peripheral Vascular Diseases; Simvastatin	1996
The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. The New England journal of medicine, 1997, Jan-16, Volume: 336, Issue:3 Topics: Adult; Aged; Anticholesteremic Agents; Anticoagulants; Cholesterol, LDL; Cholestyramine Resin; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Thrombosis; Drug Therapy, Combination; Female; Graft Occlusion, Vascular; Humans; Hypercholesterolemia; Life Tables; Lovastatin; Male; Middle Aged; Saphenous Vein; Treatment Outcome; Warfarin	1997
Rationale and design features of a clinical trial examining the effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT). SCAT Investigators. The Canadian journal of cardiology, 1997, Volume: 13, Issue:6 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Cholesterol; Coronary Angiography; Coronary Artery Disease; Disease Progression; Double-Blind Method; Enalapril; Female; Humans; Lovastatin; Male; Middle Aged; Research Design; Simvastatin; Treatment Outcome; Ventricular Function, Left	1997
Design & rationale of the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). The American journal of cardiology, 1997, Aug-01, Volume: 80, Issue:3 Topics: Aged; Cholesterol, LDL; Coronary Artery Disease; Diet, Fat-Restricted; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Lovastatin; Male; Middle Aged; Military Medicine; Research Design; Texas; Treatment Outcome; United States	1997
Lipid altering or antioxidant vitamins for patients with coronary disease and very low HDL cholesterol? The HDL-Atherosclerosis Treatment Study Design. The Canadian journal of cardiology, 1998, Volume: 14 Suppl A Topics: Adult; Aged; Antioxidants; Cholesterol, HDL; Coronary Angiography; Coronary Artery Disease; Coronary Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Myocardial Revascularization; Niacin; Simvastatin; Treatment Outcome; Vitamins	1998
Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density. Circulation, 1999, Apr-20, Volume: 99, Issue:15 Topics: Aged; Anticholesteremic Agents; Apolipoproteins B; Centrifugation, Density Gradient; Chemical Phenomena; Chemistry, Physical; Cholesterol, LDL; Colestipol; Combined Modality Therapy; Coronary Artery Disease; Drug Therapy, Combination; Humans; Hypolipidemic Agents; Lipase; Lipids; Lipolysis; Lipoproteins; Liver; Lovastatin; Male; Middle Aged; Niacin	1999
Lipid management in patients at moderate risk for coronary heart disease: insights from the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). The American journal of medicine, 1999, Aug-23, Volume: 107, Issue:2A Topics: Age Factors; Aged; Anticholesteremic Agents; Coronary Artery Disease; Coronary Disease; Diabetes Mellitus, Type 2; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Lovastatin; Male; Middle Aged; Military Personnel; Practice Guidelines as Topic; Pravastatin; Primary Prevention; Risk; Risk Factors; Sex Factors; Smoking; Texas; Treatment Outcome	1999
Effects of lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA. The cholesterol lowering atherosclerosis PTCA trial (CLAPT). European heart journal, 1999, Volume: 20, Issue:19 Topics: Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Coronary Angiography; Coronary Artery Disease; Diet; Disease Progression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Lovastatin; Male; Middle Aged; Prospective Studies; Recurrence; Time Factors	1999
Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Circulation, 2000, Feb-08, Volume: 101, Issue:5 Topics: Acute Disease; Aged; Anticholesteremic Agents; Apolipoproteins; Cohort Studies; Coronary Artery Disease; Double-Blind Method; Female; Humans; Lipids; Lovastatin; Male; Middle Aged; Military Personnel; Regression Analysis; Risk Factors; Texas	2000
Insights on treating an over-the-counter-type subgroup: data from the Air Force/Texas Coronary Atherosclerosis Prevention Study Population. The American journal of cardiology, 2000, Jun-22, Volume: 85, Issue:12A Topics: Aged; Anticholesteremic Agents; Cholesterol; Coronary Artery Disease; Female; Humans; Hyperlipidemias; Lovastatin; Male; Middle Aged; Military Personnel; Nutrition Surveys; Randomized Controlled Trials as Topic; Risk Factors; Texas	2000
Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): baseline characteristics and comparison with USA population. Journal of cardiovascular risk, 2000, Volume: 7, Issue:2 Topics: Aged; Anticholesteremic Agents; Cholesterol; Cohort Studies; Coronary Artery Disease; Diet, Fat-Restricted; Double-Blind Method; Female; Humans; Lovastatin; Male; Middle Aged; Military Personnel; Prevalence; Primary Prevention; Risk Factors; Texas	2000
Application of the National Cholesterol Education Program and joint European treatment criteria and clinical benefit in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). European heart journal, 2000, Volume: 21, Issue:19 Topics: Aged; Anticholesteremic Agents; Cholesterol, LDL; Coronary Artery Disease; Female; Humans; Hypercholesterolemia; Incidence; Lovastatin; Male; Middle Aged; Military Personnel; Patient Education as Topic; Practice Guidelines as Topic; Program Evaluation; Texas	2000
Effect of lovastatin on cardiovascular resource utilization and costs in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). AFCAPS/TexCAPS Research Group. The American journal of cardiology, 2000, Dec-01, Volume: 86, Issue:11 Topics: Aged; Anticholesteremic Agents; Coronary Artery Disease; Cost-Benefit Analysis; Diagnostic Techniques, Cardiovascular; Health Care Costs; Hospitalization; Humans; Incidence; Lovastatin; Middle Aged; Military Personnel; Myocardial Revascularization; Prospective Studies; Texas; Utilization Review	2000
Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TEXCAPS): additional perspectives on tolerability of long-term treatment with lovastatin. The American journal of cardiology, 2001, May-01, Volume: 87, Issue:9 Topics: Aged; Analysis of Variance; Anticholesteremic Agents; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Diet, Fat-Restricted; Double-Blind Method; Female; Humans; Lovastatin; Male; Middle Aged; Military Personnel; Primary Prevention; Proportional Hazards Models; Risk Factors; Texas; Treatment Outcome	2001
Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the post coronary artery bypass graft trial. Circulation, 2001, Nov-27, Volume: 104, Issue:22 Topics: Anticholesteremic Agents; Anticoagulants; Cholesterol, LDL; Cholestyramine Resin; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Vessels; Disease Progression; Female; Follow-Up Studies; Humans; Lipids; Lovastatin; Male; Middle Aged; Postoperative Period; Saphenous Vein; Treatment Outcome	2001
Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): efficacy and tolerability of long-term treatment with lovastatin in women. Journal of women's health & gender-based medicine, 2001, Volume: 10, Issue:10 Topics: Aged; Anticholesteremic Agents; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Double-Blind Method; Drug Administration Schedule; Female; Humans; Lovastatin; Male; Menopause; Middle Aged; Military Personnel; Nutrition Surveys; Texas; Treatment Outcome; Women's Health	2001
Plasma homocysteine concentration, statin therapy, and the risk of first acute coronary events. Circulation, 2002, Apr-16, Volume: 105, Issue:15 Topics: Acute Disease; Aged; Anticholesteremic Agents; C-Reactive Protein; Cholesterol, LDL; Coronary Artery Disease; Coronary Disease; Double-Blind Method; Female; Follow-Up Studies; Homocysteine; Humans; Lovastatin; Male; Middle Aged; Myocardial Infarction; Risk Factors	2002
The Monitored Atherosclerosis Regression Study (MARS). Design, methods and baseline results. The Online journal of current clinical trials, 1992, Oct-23, Volume: Doc No 26 Topics: Adult; Aged; Cholesterol; Cholesterol, Dietary; Coronary Angiography; Coronary Artery Disease; Dietary Fats; Double-Blind Method; Female; Humans; Lipoproteins; Lovastatin; Male; Middle Aged; Prospective Studies; Remission Induction; Treatment Outcome; Triglycerides	1992
Coronary atheroma regression trials. MAAS Steering Committee. Lancet (London, England), 1992, May-16, Volume: 339, Issue:8803 Topics: Coronary Artery Disease; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Middle Aged; Simvastatin	1992
Worldwide experience with simvastatin/lovastatin. European heart journal, 1992, Volume: 13 Suppl B Topics: Anticholesteremic Agents; Chemical and Drug Induced Liver Injury; Cholesterol, LDL; Coronary Artery Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Long-Term Care; Lovastatin; Rhabdomyolysis; Simvastatin	1992
Effect of lovastatin or niacin combined with colestipol and regression of coronary atherosclerosis. European heart journal, 1992, Volume: 13 Suppl B Topics: Apolipoprotein A-I; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Colestipol; Coronary Angiography; Coronary Artery Disease; Drug Therapy, Combination; Humans; Lovastatin; Male; Middle Aged; Niacin	1992
Long-term experience with lovastatin treatment in patients with coronary heart disease and hyperlipoproteinaemia type II. European heart journal, 1992, Volume: 13 Suppl B Topics: Adult; Aged; Angina Pectoris; Coronary Artery Disease; Coronary Disease; Double-Blind Method; Exercise Test; Female; Humans; Hyperlipoproteinemia Type II; Lipids; Lovastatin; Male; Middle Aged	1992
[Angiographic regression of coronary atheromatosis]. Lakartidningen, 1991, Apr-10, Volume: 88, Issue:15 Topics: Angiography; Anticholesteremic Agents; Coronary Angiography; Coronary Artery Disease; Drug Therapy, Combination; Humans; Hyperlipidemias; Lovastatin; Male; Middle Aged; Niacin; Remission Induction	1991
Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA, 1990, Dec-19, Volume: 264, Issue:23 Topics: Adult; Aged; Cholesterol, HDL; Cholesterol, LDL; Colestipol; Coronary Artery Disease; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Niacin; Radiographic Image Interpretation, Computer-Assisted; Triglycerides	1990

Other Studies

18 other study(ies) available for lovastatin and Arteriosclerosis, Coronary

Article	Year
Current perspectives on statins. Journal of the Indian Medical Association, 2003, Volume: 101, Issue:6 Topics: Adult; Aged; Anticholesteremic Agents; Cholesterol; Cholestyramine Resin; Coronary Artery Disease; Female; Humans; India; Lovastatin; Male; Middle Aged; Pravastatin; Randomized Controlled Trials as Topic; Simvastatin	2003
C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases. Medical hypotheses, 2004, Volume: 62, Issue:4 Topics: Acute-Phase Reaction; Aspirin; Atorvastatin; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Artery Disease; Heptanoic Acids; Humans; Incidence; Inflammation; Interleukin-6; Lovastatin; Pravastatin; Predictive Value of Tests; Pyrroles; Risk Factors; Simvastatin	2004
Low high-density lipoprotein cholesterol and cardiovascular disease: risk reduction with statin therapy. American heart journal, 2006, Volume: 151, Issue:3 Topics: Atorvastatin; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Particle Size; Polymorphism, Genetic; Pravastatin; Pyrroles; Risk Factors; Simvastatin	2006
Establishing the benefit of statins in low-to-moderate--risk primary prevention: the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Atherosclerosis. Supplements, 2007, Volume: 8, Issue:2 Topics: Aged; Apolipoprotein A-I; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Coronary Disease; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Lovastatin; Male; Middle Aged; Military Personnel; Patient Selection; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Texas; Time Factors; Treatment Outcome; Triglycerides	2007
The beneficial effects of HMG-coenzyme A reductase inhibitor in the primary and secondary prevention of atherosclerosis in the coronaries. Progress in cardiovascular nursing, 1996,Spring, Volume: 11, Issue:2 Topics: Anticholesteremic Agents; Coronary Artery Disease; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Middle Aged; Pravastatin	1996
Atherosclerosis and restenosis: reflections on the Lovastatin Restenosis Trial and Scandinavian Simvastatin Survival Study. The American journal of cardiology, 1996, Nov-01, Volume: 78, Issue:9 Topics: Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Coronary Artery Disease; Death, Sudden, Cardiac; Humans; Lovastatin; Myocardial Infarction; Pravastatin; Randomized Controlled Trials as Topic; Recurrence; Scandinavian and Nordic Countries; Simvastatin; Survival Analysis	1996
Prevention of atherosclerosis in coronary-artery bypass grafts. The New England journal of medicine, 1997, Jun-19, Volume: 336, Issue:25 Topics: Cholesterol, LDL; Coronary Artery Bypass; Coronary Artery Disease; Cost-Benefit Analysis; Humans; Hypercholesterolemia; Lovastatin; Recurrence; Saphenous Vein	1997
Goals for cholesterol lowering. Circulation, 1999, May-11, Volume: 99, Issue:18 Topics: Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Coronary Artery Disease; Genetic Predisposition to Disease; Goals; Humans; Lovastatin; Reference Values	1999
Update in women's health. Annals of internal medicine, 2000, Sep-05, Volume: 133, Issue:5 Topics: Anticholesteremic Agents; Breast Neoplasms; Clinical Trials as Topic; Coronary Artery Disease; Female; Humans; Lovastatin; Pravastatin; Women's Health	2000
Therapeutic impact of statin therapy in patients with low HDL cholesterol. Current atherosclerosis reports, 1999, Volume: 1, Issue:1 Topics: Anticholesteremic Agents; Cholesterol, HDL; Coronary Artery Disease; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lovastatin; Male	1999
The Air Force/Texas Coronary Atherosclerosis Prevention Study: implications for preventive cardiology in the general adult US population. Current atherosclerosis reports, 1999, Volume: 1, Issue:1 Topics: Aged; Angina, Unstable; Cholesterol, LDL; Coronary Artery Disease; Death, Sudden, Cardiac; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lovastatin; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic	1999
Inflammatory mechanisms in atherosclerosis: from laboratory evidence to clinical application. Italian heart journal : official journal of the Italian Federation of Cardiology, 2001, Volume: 2, Issue:11 Topics: C-Reactive Protein; Cholesterol, LDL; Coronary Artery Disease; Humans; Lovastatin; Randomized Controlled Trials as Topic	2001
Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation, 2002, Mar-26, Volume: 105, Issue:12 Topics: Acute Disease; Cholesterol; Clinical Trials as Topic; Comorbidity; Coronary Artery Disease; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heparin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Lovastatin; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Platelet Aggregation Inhibitors; Pravastatin; Proportional Hazards Models; Risk Factors; Simvastatin; Substance Withdrawal Syndrome; Survival Rate; Treatment Outcome; Troponin; United States	2002
Long-term prevention of premature coronary atherosclerosis in homozygous familial hypercholesterolemia. The Journal of pediatrics, 2002, Volume: 141, Issue:1 Topics: Adult; Anticholesteremic Agents; Blood Component Removal; Chemical Precipitation; Cholesterol, LDL; Combined Modality Therapy; Coronary Artery Disease; Extracorporeal Circulation; Female; Fibrinolytic Agents; Heparin; Humans; Hyperlipoproteinemia Type II; Lovastatin; Treatment Outcome	2002
[Preventive effect of simvastatin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis in cholesterol-fed rabbits]. Fukuoka igaku zasshi = Hukuoka acta medica, 1991, Volume: 82, Issue:2 Topics: Animals; Anticholesteremic Agents; Cholesterol, Dietary; Coronary Artery Disease; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Rabbits; Simvastatin	1991
[The effect of lovastatin therapy on the dynamics of the clinical state of patients with ischemic heart disease and hyperlipoproteinemia]. Terapevticheskii arkhiv, 1990, Volume: 62, Issue:8 Topics: Adult; Apolipoproteins; Cholesterol; Coronary Artery Disease; Coronary Disease; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Hyperlipoproteinemias; Lipoproteins; Lovastatin; Male; Middle Aged; Triglycerides	1990
Effects of therapy with diet and simvastatin on atherosclerosis in hypercholesterolemic patients. Cardiovascular drugs and therapy, 1990, Volume: 4, Issue:5 Topics: Adult; Aged; Anticholesteremic Agents; Combined Modality Therapy; Coronary Angiography; Coronary Artery Disease; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Simvastatin	1990
[The effectiveness of the hypolipemic preparation lovastatin in patients with ischemic heart disease and hyperlipoproteinemia]. Biulleten' Vsesoiuznogo kardiologicheskogo nauchnogo tsentra AMN SSSR, 1989, Volume: 12, Issue:2 Topics: Adult; Chronic Disease; Coronary Artery Disease; Coronary Disease; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Hyperlipoproteinemias; Lipids; Lipoproteins; Lovastatin; Male; Middle Aged	1989